Benzo[a]pyrene-dependent activation of transcription factors NF-κB and AP-1 related to tumor promotion in hepatoma cell cultures

Biochemistry (Moscow)

Volumn 72, Issue 5, 2007, Pages 552-557

  Bolotina, N A ^a,b   Gasparian, A V ^a   Dubovaja, T K ^b   Evteev, V A ^a   Kobliakov, V A ^a  

^a INSTITUTE OF BIOMEDICAL CHEMISTRY   (Russian Federation)

^b PIROGOV RUSSIAN NATIONAL RESEARCH MEDICAL UNIVERSITY   (Russian Federation)

Author keywords

Ah receptor; AP 1; Cytochrome P450; NF B; Tumor promotion

Indexed keywords

BENZENE; BIOACTIVITY; CELL CULTURE; METABOLISM; TUMORS;

AH-RECEPTORS; CYTOCHROME; ISOFORMS; TUMOR PROMOTION;

TRANSCRIPTION FACTORS;

BENZO[A]PYRENE; BENZO[A]PYRENE DERIVATIVE; BENZO[E]PYRENE; I KAPPA B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; NF KAPPAB INHIBITOR ALPHA; NF-KAPPAB INHIBITOR ALPHA; POLYCYCLIC AROMATIC HYDROCARBON; TRANSCRIPTION FACTOR AP 1; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL; ARTICLE; BIOLOGICAL MODEL; DRUG EFFECT; GEL MOBILITY SHIFT ASSAY; HUMAN; IMMUNOBLOTTING; LIVER CELL CARCINOMA; LIVER TUMOR; METABOLISM; PATHOLOGY; PHOSPHORYLATION; PROTEIN BINDING; TUMOR CELL LINE;

ANIMALS; BENZO(A)PYRENE; BENZOPYRENES; CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; ELECTROPHORETIC MOBILITY SHIFT ASSAY; HUMANS; I-KAPPA B PROTEINS; IMMUNOBLOTTING; LIVER NEOPLASMS; MODELS, BIOLOGICAL; NF-KAPPA B; PHOSPHORYLATION; POLYCYCLIC HYDROCARBONS, AROMATIC; PROTEIN BINDING; TRANSCRIPTION FACTOR AP-1; TUMOR NECROSIS FACTOR-ALPHA;

EID: 34249651218     PISSN: 00062979     EISSN: 16083040     Source Type: Journal    
DOI: 10.1134/S0006297907050124     Document Type: Article

References (35)

1. Denison, M., and Whitlock, J. (1995) Biol. Chem., 270, 18175-18178.
2. Bock, K., and Kohle, C. (2005) Biochem. Pharmacol., 69, 1403-1408.
3. Ge, N., and Elferink, C. (1998) J. Biol. Chem., 273, 22708-22713.
4. Kim, D. W., Gazourian, L., Quadri, S. A., Romieu-Mourez, R., Sherr, D. H., and Sonenshein, G. E. (2000) Oncogene, 19, 5498-5506.
5. Tian, Y., Rabson, A., and Gallo, M. (2002) Chem. Biol. Interact., 141, 97-115.
6. Kobliakov, V. A. (1998) Biochemistry (Moscow), 63, 885-898.
7. Rakitsky, V., Koblyakov, V., and Turusov, V. (2000) Teratog. Carcinog. Mutagen., 20, 229-240.
8. Gujaeva, E. L., Ostashkina, N. M., Kondalenko, V. F., and Koblyakov, V. A. (1999) Biochemistry (Moscow), 64, 929-932.
9. Sharovskaja, Yu. Yu., Vaiman, A. V., Solomatina, N. A., and Kobliakov, V. A. (2004) Biochemistry (Moscow), 69, 413-419.
10. Sharovskaya, Y., Kobliakova, I., Solomatina, N., and Kobliakov, V. (2006) Eur. J. Cell Biol., 85, 387-397.
11. Beg, A. A., and Baltimore, D. (1996) Science, 274, 782-784.
12. Chen, F., Castranova, V., and Shi, X. (2001) Am. J. Pathol., 159, 387-397.
13. Wang, C. X., Mayo, M. W., and Baldwin, A. S., Jr. (1996) Science, 274, 784-787.
14. Karin, M., Cao, Y., Greten, F. R., and Li, Z. W. (2002) Nat. Rev. Cancer, 2, 301-310.
15. Hayden, M., and Ghosh, S. (2004) Genes Dev., 18, 2195-2224.
16. Hess, J., Angel, P., and Schorpp-Kistner, M. (2004) J. Cell Sci., 117, 5965-5973.
17. Li, J., Chen, H., Ke, Q., Feng, Z., Tang, M. S., Liu, B., Amin, S., Costa, M., and Huang, C. (2004) Mol. Carcinog., 40, 104-115.
18. Shvemberger, I. N. (1970) Tsitologiya, 12, 1057-1059.
19. Lyakh, L. A., Koski, G. K., Telford, W., Gress, R. E., Cohen, P. A., and Rice, N. R. (2000) J. Immunol., 165, 3647-3655.
20. Gasparian, A. V., Yao, Y., Kowalczyk, D., Lyakh, L. A., Karseladze, A., Slaga, T., and Budunova, I. V. (2002) J. Cell Sci., 115, 141-151.
21. Green, D. (2000) Cell, 102, 1-4.
22. Ashida, H., Nagy, S., and Matsumura, F. (2000) Biochem. Pharmacol., 59, 741-751.
23. Parrish, A., Fisher, R., Brghardt, R., Gndolfi, A., Brendel, K., and Ramos, K. (1998) Toxicol. Appl. Pharmacol., 152, 302-308.
24. Yan, Z., Subbaramaiah, K., Camilli, T., Zhang, F., Tanabe, T., McCaffrey, T. A., Dannenberg, A. J., and Weksler, B. B. (2000) J. Biol. Chem., 275, 4949-4955.
25. Ma, C., Wang, J., and Luo, J. (2004) Biochem. Pharmacol., 67, 1975-1983.
26. Pei, X., Nakanishi, Y., Takayama, K., Bai, F., and Hara, N. (1999) J. Biol. Chem., 274, 35240-35246.
27. Oikawa, K., Ohbayashi, T., Mimura, J., Iwata, R., Kameta, A., Evine, K., Iwaya, K., Fujii-Kuriyama, Y., Kuroda, M., and Mukai, K. (2001) Cancer Res., 61, 5707-5709.
28. Hossain, A., Tsuchiva, S., Minegishi, M., Osada, M., Ikava, S., Tezuka, F., Kaji, M., Konno, T., Watanabe, M., and Kikuchi, H. (1998) J. Biol. Chem., 273, 19853-19858.
29. Hoffer, A., Chang, C., and Puga, A. (1996) Toxicol. Appl. Pharmacol., 141, 238-247.
30. Solhaug, A., Refsnes, M., LaEg, M., Schwarze, P. E., Husuy, T., and Holme, J. (2004) Carcinogenesis, 25, 809-819.
31. Tan, Z., Chang, X., Puga, A., and Xia, Y. (2002) Biochem. Pharmacol., 64, 771-780.
32. Lecureur, V., Ferrec, E. L., N'diaye, M., Vee, M. L., Gardyn, C., Gilot, D., and Fardel, O. (2005) FEBS Lett., 579, 1904-1910.
33. Ide, F., Suka, N., Kitada, M., Sakashita, H., Kusama, K., and Ishikawa, T. (2004) Cancer Lett., 214, 35-41.
34. Merchant, M., Wang, X., Kamps, C., Rosengren, R., Morrison, V., and Safe, S. (1992) Arch. Biochem. Biophys., 292, 250-257.
35. Kobliakov, V. A. (1995) Biochemistry (Moscow), 60, 1335-1346.